The trademark application AReSVi was filed by GlaxoSmithKline Biologicals S.A., a corporation established under the laws of the Kingdom of Belgium (the "Applicant"). Application withdrawn.
The application was filed in English (Spanish was selected as the second language).
Goods And Services
The mark was filed in class 42 with Medical and scientific research, namely, conducting clinical trials for pharmaceutical preparations for the treatment and prevention of respiratory disease and respiratory viruses.